Submission Details
| 510(k) Number | K162165 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 03, 2016 |
| Decision Date | August 29, 2017 |
| Days to Decision | 391 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K162165 is an FDA 510(k) clearance for the ambIT PCA*PIB, ambIT PIB, ambIT PIB*PCA, ambIT PIEB, and ambIT Programmable Intermittent Pump, a Pump, Infusion, Pca (Class II — Special Controls, product code MEA), submitted by Summit Medical Products, Inc. (Sandy, US). The FDA issued a Cleared decision on August 29, 2017, 391 days after receiving the submission on August 3, 2016. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5725.
| 510(k) Number | K162165 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 03, 2016 |
| Decision Date | August 29, 2017 |
| Days to Decision | 391 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | MEA — Pump, Infusion, Pca |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5725 |